C. Michael Gibson discusses 1-year results from this high-risk patient series with Mayra Guerrero. Receive the the latest news, research, and presentations from major meetings right to your inbox.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Transcatheter aortic ... instructions to help you with your recovery, which may include a special diet, exercise, and medicine. Regular check-ups are very important. It is easier for patients with a ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Open heart surgery for aortic or mitral valve repair or replacement has traditionally required ... associated with a shorter hospital stays (by about one to two days), faster recovery, less bleeding ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world’s first living mitral ...

C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...

If a valve, such as the aortic or mitral ... for valve replacement are minimally invasive surgeries, which avoid a large ...

Physicians at the WVU Heart and Vascular Institute (HVI) are the first in the state and region to perform transcatheter ...